Intrust Bank Na Madrigal Pharmaceuticals, Inc. Transaction History
Intrust Bank Na
- $1.19 Billion
- Q3 2025
A detailed history of Intrust Bank Na transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 674 shares of MDGL stock, worth $364,971. This represents 0.03% of its overall portfolio holdings.
Number of Shares
674Holding current value
$364,971% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
383Shares Held
23.3MCall Options Held
729KPut Options Held
473K-
Janus Henderson Group PLC London, X02.19MShares$1.19 Billion0.34% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.09MShares$1.13 Billion32.86% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.08 Billion9.27% of portfolio
-
Baker Bros. Advisors LP New York, NY1.98MShares$1.07 Billion6.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.88MShares$1.02 Billion10.35% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.26B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...